Meeder Asset Management Inc Bio Rad Laboratories, Inc. Transaction History

Meeder Asset Management Inc

$1.48 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$304.11 - $351.99 $81,197 - $93,981	-267 Reduced 58.55%	189 $65,000
Q1 2023 May 15, 2023	BUY	$418.69 - $503.0 $190,922 - $229,368	456 New	456 $218,000
Q3 2022 Nov 14, 2022	SELL	$412.59 - $563.26 $55,287 - $75,476	-134 Reduced 64.73%	73 $30,000
Q2 2022 Aug 08, 2022	SELL	$463.67 - $597.16 $67,232 - $86,588	-145 Reduced 41.19%	207 $102,000
Q1 2022 May 10, 2022	SELL	$524.57 - $735.42 $327,331 - $458,902	-624 Reduced 63.93%	352 $198,000
Q4 2021 Feb 11, 2022	BUY	$708.84 - $794.68 $34,024 - $38,144	48 Added 5.17%	976 $738,000
Q3 2021 Nov 08, 2021	SELL	$657.71 - $825.77 $13,811 - $17,341	-21 Reduced 2.21%	928 $692,000
Q2 2021 Aug 09, 2021	SELL	$576.64 - $649.04 $134,933 - $151,875	-234 Reduced 19.78%	949 $611,000
Q1 2021 Apr 28, 2021	BUY	$547.01 - $662.35 $624,138 - $755,741	1,141 Added 2716.67%	1,183 $676,000
Q4 2020 Feb 09, 2021	SELL	$510.68 - $643.45 $494,338 - $622,859	-968 Reduced 95.84%	42 $24,000
Q3 2020 Nov 02, 2020	BUY	$454.43 - $535.6 $17,722 - $20,888	39 Added 4.02%	1,010 $521,000
Q2 2020 Aug 11, 2020	BUY	$334.87 - $493.06 $2,344 - $3,451	7 Added 0.73%	971 $440,000
Q1 2020 May 15, 2020	BUY	$320.01 - $409.07 $113,603 - $145,219	355 Added 58.29%	964 $339,000
Q4 2019 Feb 13, 2020	BUY	$319.73 - $374.2 $6,074 - $7,109	19 Added 3.22%	609 $225,000
Q3 2019 Oct 17, 2019	BUY	$304.55 - $345.24 $137,047 - $155,358	450 Added 321.43%	590 $197,000
Q2 2019 Aug 05, 2019	BUY	$286.93 - $312.59 $860 - $937	3 Added 2.19%	140 $44,000
Q4 2018 Jan 17, 2019	SELL	$220.1 - $309.0 $749,880 - $1.05 Million	-3,407 Reduced 96.13%	137 $32,000
Q3 2018 Nov 02, 2018	BUY	$289.28 - $326.15 $476,444 - $537,169	1,647 Added 86.82%	3,544 $0
Q2 2018 Jul 24, 2018	BUY	$244.1 - $303.88 $449,632 - $559,746	1,842 Added 3349.09%	1,897 $0
Q1 2018 May 03, 2018	SELL	$233.97 - $274.11 $50,537 - $59,207	-216 Reduced 79.7%	55 $14,000
Q4 2017 Feb 02, 2018	SELL	$216.94 - $271.3 $75,278 - $94,141	-347 Reduced 56.15%	271 $65,000
Q3 2017 Oct 20, 2017	BUY	$212.27 - $242.28 $131,182 - $149,729	618	618 $137,000

Others Institutions Holding BIO

# of Institutions

457

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.41B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Account